Panagiotis Tsirigotis

14PUBLICATIONS
42CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTransplantation immunologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 19, 2026
Caplacizumab as an Emerging Treatment for Patients With Thrombotic Thrombocytopenic Purpura Presenting With Acute Ischemic Stroke.

Konstantinos Melanis, Aikaterini Theodorou, Lina Palaiodimou

|Oct 23, 2025
Low-dose post-transplant cyclophosphamide in combination with low-dose alemtuzumab for graft-versus-host-disease prevention in mismatched unrelated allogeneic stem cell transplantation is associated with improved outcomes and reduced toxicity.

Ioanna Lazana, Konstantinos Gkirkas, Ioannis Konstantellos

|Sep 27, 2025
Donor-derived malignancy after allogeneic stem cell transplantation: a rare but well recognized complication.

Panagiotis Tsirigotis, Ioanna Lazana

|Feb 26, 2025
The Prognostic Impact of Additional Molecular and Cytogenetic Abnormalities on AML Patients with NPM1- and/or FLT3-ITD Mutations Receiving Intensive Chemotherapy: Real-World Data from the Greek Registry.

Ioanna Lazana, Maria Papathanassiou, Ioannis Konstantellos

|Aug 22, 2022
Donor lymphocyte infusion (DLI) post haploidentical stem cell transplantation (Haplo) with post-transplant cyclophosphamide (PTCy): crossing the human leukocyte antigen (HLA) barrier.

Arnon Nagler, Panagiotis Tsirigotis

|Apr 01, 2022
Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT.

Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger

Pageof 3

Frequent Collaborators

3 joint publications

Patrick J Hayden

3 joint publications

Ioanna Lazana

2 joint publications

Sotirios Papageorgiou

2 joint publications

Donal P McLornan